1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with suramin in 4 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (suramin) | Trials (suramin) | Recent Studies (post-2010) (suramin) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 3,023 | 92 | 431 |
Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | suramin (IC50) |
---|---|---|---|
ATP-dependent 6-phosphofructokinase | Trypanosoma brucei brucei | 3 | |
Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 9.76 | |
P2X purinoceptor 2 | Rattus norvegicus (Norway rat) | 4 | |
DNA-dependent protein kinase catalytic subunit | Homo sapiens (human) | 1.7 | |
DNA primase | Mycobacterium tuberculosis CDC1551 | 8.2 | |
RmtA | Aspergillus nidulans | 5.9 | |
Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | 9.4 | |
NAD-dependent protein deacetylase sirtuin-2 | Homo sapiens (human) | 1.15 | |
NAD-dependent protein deacetylase sirtuin-1 | Homo sapiens (human) | 1.5667 | |
Protein arginine N-methyltransferase 1 | Homo sapiens (human) | 5.33 | |
NAD-dependent protein deacylase sirtuin-5, mitochondrial | Homo sapiens (human) | 2.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Benito, A; Fernández-Luna, JL; Gajate, C; Martín-Martín, B; Martínez-Dalmau, R; Modolell, M; Mollinedo, F | 1 |
Hanahan, DJ; Javors, MA; Siafaka-Kapadai, A; Svetlov, S | 1 |
Altomare, A; Behar, J; Biancani, P; Harnett, KM; Ma, J; Rieder, F | 1 |
Kanai, S; Katakura, F; Kinoshita, R; Koie, H; Nakayama, S; Narita, T; Okabayashi, K; Takeuchi, R; Yamauchi, T | 1 |
4 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and suramin
Article | Year |
---|---|
Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L).
Topics: Albumins; Animals; Antineoplastic Agents; Apoptosis; bcl-X Protein; Gene Expression; Genes, bcl-2; Humans; Lymphocytes; Mice; Monocytes; Phospholipid Ethers; Platelet Activating Factor; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Suramin; Tumor Cells, Cultured | 1997 |
Effects of suramin on human platelet aggregation and Ca2+ mobilization induced by thrombin and other agonists.
Topics: Antineoplastic Agents; Arachidonic Acid; Blood Platelets; Calcium; Dose-Response Relationship, Drug; Drug Antagonism; Humans; Phosphatidic Acids; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Signal Transduction; Suramin; Thrombin | 1998 |
ATP: a mediator for HCl-induced TRPV1 activation in esophageal mucosa.
Topics: Acetyltransferases; Adenosine Triphosphate; Animals; Antineoplastic Agents; Calcitonin Gene-Related Peptide; Cell Line; Esophagus; Humans; Hydrochloric Acid; Mucous Membrane; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Platelet Activating Factor; Rabbits; Real-Time Polymerase Chain Reaction; Receptors, Purinergic; Substance P; Suramin; TRPV Cation Channels | 2011 |
Activation of canine neutrophils by platelet-activating factor.
Topics: Animals; Calcium; Dogs; Neutrophils; Platelet Activating Factor; Reactive Oxygen Species; Receptors, G-Protein-Coupled; Signal Transduction; Suramin | 2021 |